Literature DB >> 615833

Chronic hepatitis: a problem for the pathologist.

P J Scheuer.   

Abstract

The accepted histological categories of chronic hepatitis are chronic persistent hepatitis (CPH) and chronic active or aggressive hepatitis (CAH). A third form, chronic lobular hepatitis (CLH), encompasses those cases in which the lesion is predominantly within the lobules and in which portal and periportal inflammation are mild. CLH has many synonyms. International agreement on a reproducible and rational nomenclature of chronic hepatitis is still far from complete. CPH is characterized by portal inflammation. Histological definition is simple, but there are diagnostic pitfalls. The category may need subdivision on the basis of immunological studies. CAH should be regarded as a complex rather than a single disease, and it is important to specify the aetiology and pathological components in each instance. The concept of CAH must be altered to incorporate the lesion of bridging hepatic necrosis (BHN). Piecemeal necrosis, accompanied by inflammatory infiltration, is considered to be the most important of the various pathogenetic factors in CAH, but BHN probably plays a significant part in accelerating the development of cirrhosis. An excessive portal and periportal inflammatory reaction with or without BHN, in a liver biopsy taken during the course of an acute hepatitis, helps to predict a possible chronic course.

Entities:  

Mesh:

Year:  1977        PMID: 615833     DOI: 10.1111/j.1365-2559.1977.tb01640.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

1.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up.

Authors:  R G Chadwick; J Galizzi; J Heathcote; T Lyssiotis; B J Cohen; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

Review 3.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

4.  Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis.

Authors:  D Müting; J F Kalk; R Fischer; H Wuzel; J Reikowski
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

5.  Chronic active hepatitis in intravenous drug abusers may be delta agent infection associated.

Authors:  A G Shattock; Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1984-01       Impact factor: 1.568

6.  The course of chronic persistent hepatitis.

Authors:  Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1982-03       Impact factor: 1.568

7.  The effects of drug abuse on the natural history and progression of chronic active and chronic persistent hepatitis.

Authors:  Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1981-04       Impact factor: 1.568

Review 8.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

9.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization.

Authors:  P P Anthony; K G Ishak; N C Nayak; H E Poulsen; P J Scheuer; L H Sobin
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

10.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.